Martin Tami Tillotson 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Tax Payment
Common Stock
2024-02-22$27.94/sh−246$6,873→ 86,168 total - Disposition to Issuer
Restricted Stock Units
2024-02-22−750→ 1,500 total→ Common Stock (750 underlying) - Award
Common Stock
2024-02-22+750→ 86,414 total
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.